|
As we near the opening of phase 2 in April, and with information on vaccinations changing literally daily, HC365 would direct you to the latest informative bulletin from Infectious Disease Specialist, Dr. Andrew Morris.
Dr. Morris has a weekly newsletter which you can subscribe to with digestible scientific and pertinent information on Covid-19, the status of the infections, and the supporting vaccines which will aid in slowing the pandemic.
Per the most recent media release, Canada's National Advisory Committee on Immunization (NACI) is recommending provinces pause the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns - guidance most provinces said today that they would follow.
The change comes following reports out of Europe of very rare instances of blood clots in some immunized patients-predominantly in women under the age of 55.
Dr. Shelley Deeks, the vice-chair of NACI, said that with "substantial uncertainty" around cases of vaccine-induced thrombocytopenia (VIPIT) in people with low platelets, the committee is recommending the suspension of shots in all people under 55 as a "precautionary measure".
Based on early research out of Europe, VIPIT continues to remain a rare incidence varying as the data emerges.
NOTEWORTHY: According to the CBC News: 300,000 of the AZ shots have been administered in Canada already, with no reports of blood clots.
Stay Safe and Healthy,
Dr. Vera Kohut and the Covid team
|
